Gifford Fong Associates - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Gifford Fong Associates ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$1,094
-17.2%
29,0000.0%0.26%
-15.5%
Q2 2023$1,321
+12.3%
29,0000.0%0.31%0.0%
Q1 2023$1,176
-20.4%
29,0000.0%0.31%
-8.6%
Q4 2022$1,478
-99.9%
29,0000.0%0.34%
-12.2%
Q3 2022$1,562,000
-16.2%
29,0000.0%0.39%
-11.1%
Q2 2022$1,863,000
-17.2%
29,0000.0%0.43%
+5.6%
Q1 2022$2,249,000
-9.6%
29,0000.0%0.41%
-5.5%
Q4 2021$2,489,000
+6.7%
29,0000.0%0.44%
-4.0%
Q3 2021$2,332,000
-0.1%
29,0000.0%0.45%
-0.2%
Q2 2021$2,335,000
-4.5%
29,0000.0%0.45%
-13.7%
Q1 2021$2,446,000
+5.1%
29,0000.0%0.53%
-2.6%
Q4 2020$2,327,000
-0.2%
29,0000.0%0.54%
-13.6%
Q3 2020$2,332,000
-6.6%
29,0000.0%0.62%
-17.3%
Q2 2020$2,497,000
+6.0%
29,0000.0%0.76%
-12.5%
Q1 2020$2,355,000
-2.9%
29,0000.0%0.86%
+22.0%
Q4 2019$2,425,000
-4.4%
29,0000.0%0.71%
-14.7%
Q3 2019$2,537,000
+6.8%
29,0000.0%0.83%
+4.4%
Q2 2019$2,375,000
+0.7%
29,0000.0%0.80%
+2.1%
Q1 2019$2,358,000
+23.5%
29,0000.0%0.78%
+8.0%
Q4 2018$1,909,000
-14.6%
29,0000.0%0.72%
+1.4%
Q3 2018$2,236,000
+4.4%
29,0000.0%0.71%
-3.9%
Q2 2018$2,141,000
+13.5%
29,0000.0%0.74%
-3.9%
Q1 2018$1,886,00029,0000.77%
Other shareholders
BAXTER INTL INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 298,721$23,969,0008.70%
GENERATION INVESTMENT MANAGEMENT LLP 17,424,560$1,398,147,0006.24%
Soditic Asset Management LLP 77,950$6,255,0006.24%
Veritas Asset Management LLP 11,110,132$891,477,0005.32%
Dash Acquisitions Inc. 84,560$6,785,0004.74%
Prosight Management, LP 121,075$9,715,0004.49%
TSFG, LLC 94,977$7,621,0004.07%
CINCINNATI FINANCIAL CORP 1,344,648$107,895,0002.93%
Dundas Partners LLP 204,535$19,304,0002.82%
Unified Trust Company, N.A. 59,491$4,689,0002.72%
View complete list of BAXTER INTL INC shareholders